Investors' COVID Vax Suit Against Drugmaker Tossed

By P.J. D'Annunzio · March 3, 2023, 8:43 PM EST

Citing inadequate claims, a Pennsylvania federal judge on Friday tossed a proposed class action against biopharmaceutical company Ocugen Inc. filed by investors claiming the company made misleading statements regarding a COVID-19...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

IN RE: OCUGEN, INC. SECURITIES LITIGATION

Case Number

2:21-cv-02725

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Securities/Commodities

Date Filed

June 17, 2021